Simpson–Golabi–Behmel syndrome (SGBS) results from mutations in the Glypican 3 (GPC3) gene, disrupting the Wnt/β-catenin pathway and promoting uncontrolled cell growth, which increases the risk of HB [16]. The gene discussed is GPC3; the disease is Simpson-Golabi-Behmel syndrome.